Study RTD-01 is a non-interventional, pilot study designed to determine if a specific coded SMS text message study tool is effective in collecting daily real time safety data in subjects participating in clinical trials.
This study is to determine if a daily SMS text message study tool will improve adverse event and concomitant medication reporting. Patient reported adverse events and changes in concomitant medications are essential in clinical trials to determine drug-related symptoms and side effects. This study will help identify the benefits and challenges of real time daily reported outcome measures that can later be implemented in future clinical trials to enhance trial outcomes. In addition, data collected from this study will support a more sophisticated safety study tool for future study participants.
Study Type
OBSERVATIONAL
Enrollment
20
Perseverance Research Center, LLC
Scottsdale, Arizona, United States
To improve AE and concomitant medication reporting
Data collected daily through secure text messaging
Time frame: 6 weeks
Decrease recall bias
Daily reporting of AEs and concomitant medication changes
Time frame: 6 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.